Large-scale testing (Phase 3)Study completedNCT00567918
What this trial is testing
Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
Who this might be right for
KeratoconjunctivitisConjunctivitis
Astellas Pharma Inc 52